6 Pulmonary Embolism Clinical Trials in Greenville, NC (2026)

Q: How do I join a clinical trial in Greenville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you.

Recruiting Pulmonary Embolism Studies in Greenville

NCT06628453Recruiting

CGM for Management of Type 2 Diabetes in Pregnancy

The goal of this clinical trial is to learn if continuous glucose monitoring works better than self-monitoring of blood glucose (fingersticks) to treat type 2 diabetes in pregnancy. It will also learn...

Greenville, NCNA564 participantsUniversity of Alabama at Birmingham

View Study Details

NCT06777901Recruiting

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is tr...

Greenville, NCPHASE4224 participantsAngiodynamics, Inc.

View Study Details

NCT07101250Recruiting

Preoperative Acetazolamide

The goal of this randomized study looks at whether giving patients a medicine called acetazolamide (also called Diamox) before they have laparoscopic hysterectomy may decrease postoperative pain. Rese...

Greenville, NCPHASE4100 participantsPrisma Health-Upstate

View Study Details

NCT05070845Recruiting

Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

This is a Phase 2, open-label, multicenter, multiple subcutaneous injection, safety and efficacy study of PF-06835375 in adult participants with primary immune thrombocytopenia (ITP). This study will ...

Greenville, NCPHASE291 participantsPfizer

View Study Details

NCT07059000Recruiting

A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)

The purpose of this study is to evaluate the efficacy and safety of KIg 10 (Intravenous Immunoglobulin 10%) in adult patients with chronic primary ITP...

Greenville, NCPHASE340 participantsKedrion S.p.A.

View Study Details

NCT07222085Recruiting

Long-Term Stability of the Glide Control Strategy

This research is intended to test whether the prescription of the Glide prosthesis control system reduces the burden of use for both patients and their clinical care team as compared to use of Pattern...

Greenville, NCNA12 participantsInfinite Biomedical Technologies

View Study Details

About Pulmonary Embolism Clinical Trials in Greenville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 6 pulmonary embolism clinical trials recruiting participants in Greenville, NC. These studies are seeking a combined 1,031 participants. Research is being sponsored by University of Alabama at Birmingham, Angiodynamics, Inc., Prisma Health-Upstate and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Greenville — FAQ

Are there pulmonary embolism clinical trials in Greenville?

Yes, there are 6 pulmonary embolism clinical trials currently recruiting in Greenville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Greenville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Greenville research site will contact you about next steps.

Are clinical trials in Greenville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Greenville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 6 active trials in Greenville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated September 5, 2026 from ClinicalTrials.gov